We termed these Xrcc4/Trp53 deficient B lineage tumors G1XP lymphomas, and employed the whole genome NGS technique to globally assess the level of genomic complexity in six G1XP lymphoma samples. This evidence concerns the gene XRCC4 and lymphoma.